We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

QSR:NYSERestaurant Brands International Inc. Analysis

Data as of 2026-06-12 - not real-time

$73.90

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Restaurant Brands International delivered a solid Q1 2026 performance, beating consensus revenue expectations with a 7.3% year‑over‑year increase to $2.26 billion and a non‑GAAP EPS of $0.86 that topped forecasts. The stock is trading just below its 20‑day simple moving average (~$74) while the 20‑day SMA sits under the 50‑day SMA, indicating a modest short‑term bias, and the MACD line has crossed just above the signal line, delivering a bullish histogram signal amid rising volume. Fundamentally, the company maintains healthy operating margins (≈26%) and a strong free‑cash‑flow generation that comfortably covers its 3.5% dividend, though the payout ratio hovers around 80%.
Valuation concerns arise from elevated multiples (P/E ≈24, P/B ≈7) and a DCF‑derived fair value far below the current price, compounded by a very high debt‑to‑equity ratio that amplifies financial risk. The stock’s beta is low, volatility is moderate (~27% 30‑day), and the consumer‑cyclical sector faces typical regulatory and geographic exposures. Overall, the earnings beat and dividend yield support a short‑term buying opportunity, but the overvalued pricing and leverage suggest a more cautious stance for medium‑ to long‑term horizons.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Q1 earnings beat and revenue acceleration
  • Bullish MACD crossover with increasing volume
  • Attractive dividend yield with sustainable cash flow

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong operating margins and cash generation
  • High leverage raising financing risk
  • Valuation still above fair‑value benchmarks

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Brand portfolio resilience and dividend income
  • Persistent overvaluation relative to DCF
  • Elevated debt levels limiting upside potential

Key Metrics & Analysis

Financial Health

Revenue Growth7.30%
Profit Margin9.96%
P/E Ratio23.8
ROE28.14%
ROA6.44%
Debt/Equity296.41
P/B Ratio6.9
Op. Cash Flow$1.7B
Free Cash Flow$1.6B

Technical Analysis

TrendNeutral
RSI46.7
Support$70.99
Resistance$77.35
MA 20$74.20
MA 50$76.74
MA 200$70.57
MACDBullish
VolumeIncreasing
Fear & Greed Index87.21

Valuation

Fair Value$32.25
Target Price$85.92
Upside/Downside16.27%
GradeOvervalued
TypeGrowth
Dividend Yield3.52%

Risk Assessment

Beta0.19
Volatility26.94%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.